TRAZODONE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Trazodone, and what generic alternatives are available?
Trazodone is a drug marketed by Accord Hlthcare, Aiping Pharm Inc, Alvogen, Am Therap, Apotex, Apotex Inc, Aurobindo Pharma, Crossmedika Sa, Granules, Graviti Pharms, Natco, Oxford Pharms, Pharmobedient, Pliva, Quantum Pharmics, Rising, Sun Pharm Industries, Teva, Teva Pharms Usa, Torrent, Usl Pharma, Watson Labs, and Zydus Pharms. and is included in thirty-two NDAs.
The generic ingredient in TRAZODONE is trazodone hydrochloride. There are fourteen drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the trazodone hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Trazodone
A generic version of TRAZODONE was approved as trazodone hydrochloride by APOTEX on March 25th, 1987.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for TRAZODONE?
- What are the global sales for TRAZODONE?
- What is Average Wholesale Price for TRAZODONE?
Summary for TRAZODONE
| US Patents: | 0 |
| Applicants: | 23 |
| NDAs: | 32 |
| Drug Prices: | Drug price information for TRAZODONE |
| Drug Sales Revenues: | Drug sales revenues for TRAZODONE |
| DailyMed Link: | TRAZODONE at DailyMed |



